January 20, 2010. Cambridge, MA. Virtify, the market leader in enterprise content compliance solutions for the life sciences industry, has received a majority investment from Tudor Ventures, a Boston-based growth equity firm.
Many life sciences companies are ill-suited to effectively navigate today’s regulatory environment. In fact, the inability to do so can often be measured in revenue lost to product delays, regulatory fines and lost market opportunities. Virtify offers the industry’s first open technology platform to effectively manage regulatory content, compliance, and the many critical processes that are required across the complete product continuum.Bob Forlenza, Managing Partner, Tudor Ventures